Jonathan Kellerman
Advertisement
Jonathan Kellerman is manager of, the Pharmaceutical Industry Compliance and Risk Management Practice at PricewaterhouseCoopers LLP.
Articles by Jonathan Kellerman
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Johnson and Johnson’s Darzalex Faspro for Adults with High-Risk Smoldering Multiple Myeloma
2
Pharmaceutical Executive Daily: Lilly and Novo Nordisk Bring GLP-1s to TrumpRX
3
FDA Continues to Expand National Priority Voucher Program
4
In Obesity Care, NPs and PAs Are the Influencers Marketers Can’t Ignore
5
